Reduced viscosity Barley β-Glucan versus placebo: a randomized controlled trial of the effects on insulin sensitivity for individuals at risk for diabetes mellitus

<p>Abstract</p> <p>Background</p> <p>Prior studies suggest soluble fibers may favorably affect glucose/insulin metabolism.</p> <p>Methods</p> <p>This prospective, randomized, placebo controlled, double blind, parallel group trial evaluated 50 gen...

Full description

Bibliographic Details
Main Authors: Schmelzer Wade, Kolberg Lore, Williams Carolyn, Bell Margie, Frestedt Joy L, Bays Harold, Anderson James W
Format: Article
Language:English
Published: BMC 2011-08-01
Series:Nutrition & Metabolism
Subjects:
Online Access:http://www.nutritionandmetabolism.com/content/8/1/58
_version_ 1818379656666021888
author Schmelzer Wade
Kolberg Lore
Williams Carolyn
Bell Margie
Frestedt Joy L
Bays Harold
Anderson James W
author_facet Schmelzer Wade
Kolberg Lore
Williams Carolyn
Bell Margie
Frestedt Joy L
Bays Harold
Anderson James W
author_sort Schmelzer Wade
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Prior studies suggest soluble fibers may favorably affect glucose/insulin metabolism.</p> <p>Methods</p> <p>This prospective, randomized, placebo controlled, double blind, parallel group trial evaluated 50 generally healthy subjects without prior diagnosis of diabetes mellitus (44 completers), who were administered beverages containing placebo (control), lower dose (3 g/d), or higher dose (6 g/d) reduced viscosity barley β-glucan (BBG) extract. Subjects (68% women) mean age 56 years, Body Mass Index (BMI) 32 kg/m<sup>2 </sup>and baseline fasting plasma glucose 102 mg/dl were instructed to follow a weight-maintaining Therapeutic Lifestyle Changes (TLC) diet and consumed three 11 oz study beverages daily with meals for 12 weeks. The four primary study endpoint measures were plasma glucose and insulin [each fasting and post-Oral Glucose Tolerance Testing (OGTT)].</p> <p>Results</p> <p>Compared to placebo, administration of 3 g/d BBG over 12 weeks significantly reduced glucose incremental Area Under the Curve (iAUC) measures during OGTT and 6 g/d BBG over 12 weeks significantly reduced fasting insulin as well as the related homeostasis model assessment of insulin resistance (HOMA-IR). Beverages were generally well tolerated with no serious adverse experiences and no significant differences between groups for adverse experiences. Per protocol instruction, subjects maintained body weight.</p> <p>Conclusions</p> <p>These findings suggest 6 g/d BBG consumed in a beverage over 12 weeks may improve insulin sensitivity among hyperglycemic individuals with no prior diagnosis of diabetes mellitus, and who experience no change in body weight.</p> <p>Trial Registration</p> <p>ClinicalTrials.gov Identifier: NCT01375803<a href="http://www.clinicaltrials.gov/ct2/show/NCT00820807"/>.</p>
first_indexed 2024-12-14T02:06:16Z
format Article
id doaj.art-7cf95595e2d24139a2156bf568b29c11
institution Directory Open Access Journal
issn 1743-7075
language English
last_indexed 2024-12-14T02:06:16Z
publishDate 2011-08-01
publisher BMC
record_format Article
series Nutrition & Metabolism
spelling doaj.art-7cf95595e2d24139a2156bf568b29c112022-12-21T23:20:54ZengBMCNutrition & Metabolism1743-70752011-08-01815810.1186/1743-7075-8-58Reduced viscosity Barley β-Glucan versus placebo: a randomized controlled trial of the effects on insulin sensitivity for individuals at risk for diabetes mellitusSchmelzer WadeKolberg LoreWilliams CarolynBell MargieFrestedt Joy LBays HaroldAnderson James W<p>Abstract</p> <p>Background</p> <p>Prior studies suggest soluble fibers may favorably affect glucose/insulin metabolism.</p> <p>Methods</p> <p>This prospective, randomized, placebo controlled, double blind, parallel group trial evaluated 50 generally healthy subjects without prior diagnosis of diabetes mellitus (44 completers), who were administered beverages containing placebo (control), lower dose (3 g/d), or higher dose (6 g/d) reduced viscosity barley β-glucan (BBG) extract. Subjects (68% women) mean age 56 years, Body Mass Index (BMI) 32 kg/m<sup>2 </sup>and baseline fasting plasma glucose 102 mg/dl were instructed to follow a weight-maintaining Therapeutic Lifestyle Changes (TLC) diet and consumed three 11 oz study beverages daily with meals for 12 weeks. The four primary study endpoint measures were plasma glucose and insulin [each fasting and post-Oral Glucose Tolerance Testing (OGTT)].</p> <p>Results</p> <p>Compared to placebo, administration of 3 g/d BBG over 12 weeks significantly reduced glucose incremental Area Under the Curve (iAUC) measures during OGTT and 6 g/d BBG over 12 weeks significantly reduced fasting insulin as well as the related homeostasis model assessment of insulin resistance (HOMA-IR). Beverages were generally well tolerated with no serious adverse experiences and no significant differences between groups for adverse experiences. Per protocol instruction, subjects maintained body weight.</p> <p>Conclusions</p> <p>These findings suggest 6 g/d BBG consumed in a beverage over 12 weeks may improve insulin sensitivity among hyperglycemic individuals with no prior diagnosis of diabetes mellitus, and who experience no change in body weight.</p> <p>Trial Registration</p> <p>ClinicalTrials.gov Identifier: NCT01375803<a href="http://www.clinicaltrials.gov/ct2/show/NCT00820807"/>.</p>http://www.nutritionandmetabolism.com/content/8/1/58insulin sensitivityinsulinemiaglycemiabarley beta glucanrandomized controlled trial
spellingShingle Schmelzer Wade
Kolberg Lore
Williams Carolyn
Bell Margie
Frestedt Joy L
Bays Harold
Anderson James W
Reduced viscosity Barley β-Glucan versus placebo: a randomized controlled trial of the effects on insulin sensitivity for individuals at risk for diabetes mellitus
Nutrition & Metabolism
insulin sensitivity
insulinemia
glycemia
barley beta glucan
randomized controlled trial
title Reduced viscosity Barley β-Glucan versus placebo: a randomized controlled trial of the effects on insulin sensitivity for individuals at risk for diabetes mellitus
title_full Reduced viscosity Barley β-Glucan versus placebo: a randomized controlled trial of the effects on insulin sensitivity for individuals at risk for diabetes mellitus
title_fullStr Reduced viscosity Barley β-Glucan versus placebo: a randomized controlled trial of the effects on insulin sensitivity for individuals at risk for diabetes mellitus
title_full_unstemmed Reduced viscosity Barley β-Glucan versus placebo: a randomized controlled trial of the effects on insulin sensitivity for individuals at risk for diabetes mellitus
title_short Reduced viscosity Barley β-Glucan versus placebo: a randomized controlled trial of the effects on insulin sensitivity for individuals at risk for diabetes mellitus
title_sort reduced viscosity barley β glucan versus placebo a randomized controlled trial of the effects on insulin sensitivity for individuals at risk for diabetes mellitus
topic insulin sensitivity
insulinemia
glycemia
barley beta glucan
randomized controlled trial
url http://www.nutritionandmetabolism.com/content/8/1/58
work_keys_str_mv AT schmelzerwade reducedviscositybarleybglucanversusplaceboarandomizedcontrolledtrialoftheeffectsoninsulinsensitivityforindividualsatriskfordiabetesmellitus
AT kolberglore reducedviscositybarleybglucanversusplaceboarandomizedcontrolledtrialoftheeffectsoninsulinsensitivityforindividualsatriskfordiabetesmellitus
AT williamscarolyn reducedviscositybarleybglucanversusplaceboarandomizedcontrolledtrialoftheeffectsoninsulinsensitivityforindividualsatriskfordiabetesmellitus
AT bellmargie reducedviscositybarleybglucanversusplaceboarandomizedcontrolledtrialoftheeffectsoninsulinsensitivityforindividualsatriskfordiabetesmellitus
AT frestedtjoyl reducedviscositybarleybglucanversusplaceboarandomizedcontrolledtrialoftheeffectsoninsulinsensitivityforindividualsatriskfordiabetesmellitus
AT baysharold reducedviscositybarleybglucanversusplaceboarandomizedcontrolledtrialoftheeffectsoninsulinsensitivityforindividualsatriskfordiabetesmellitus
AT andersonjamesw reducedviscositybarleybglucanversusplaceboarandomizedcontrolledtrialoftheeffectsoninsulinsensitivityforindividualsatriskfordiabetesmellitus